Modern Healthcare Technology Holdings Limited

SEHK:919 주식 보고서

시가총액: HK$81.4m

Modern Healthcare Technology Holdings 미래 성장

Future 기준 확인 0/6

현재 Modern Healthcare Technology Holdings 의 성장과 수익을 예측할 만큼 분석가의 범위가 충분하지 않습니다.

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Consumer Services 수익 성장21.4%
매출 성장률n/a
향후 자기자본 수익률n/a
애널리스트 커버리지

None

마지막 업데이트n/a

최근 미래 성장 업데이트

Recent updates

A Look At The Fair Value Of Modern Healthcare Technology Holdings Limited (HKG:919)

Oct 04
A Look At The Fair Value Of Modern Healthcare Technology Holdings Limited (HKG:919)

Modern Healthcare Technology Holdings Limited (HKG:919) Not Doing Enough For Some Investors As Its Shares Slump 27%

Oct 04
Modern Healthcare Technology Holdings Limited (HKG:919) Not Doing Enough For Some Investors As Its Shares Slump 27%

It Looks Like Modern Healthcare Technology Holdings Limited's (HKG:919) CEO May Expect Their Salary To Be Put Under The Microscope

Aug 21
It Looks Like Modern Healthcare Technology Holdings Limited's (HKG:919) CEO May Expect Their Salary To Be Put Under The Microscope

Investors Aren't Buying Modern Healthcare Technology Holdings Limited's (HKG:919) Revenues

Apr 08
Investors Aren't Buying Modern Healthcare Technology Holdings Limited's (HKG:919) Revenues

Investors Don't See Light At End Of Modern Healthcare Technology Holdings Limited's (HKG:919) Tunnel And Push Stock Down 29%

Dec 18
Investors Don't See Light At End Of Modern Healthcare Technology Holdings Limited's (HKG:919) Tunnel And Push Stock Down 29%

Modern Healthcare Technology Holdings (HKG:919) Is Experiencing Growth In Returns On Capital

Jun 30
Modern Healthcare Technology Holdings (HKG:919) Is Experiencing Growth In Returns On Capital

Be Wary Of Modern Healthcare Technology Holdings (HKG:919) And Its Returns On Capital

May 04
Be Wary Of Modern Healthcare Technology Holdings (HKG:919) And Its Returns On Capital

Modern Healthcare Technology Holdings (HKG:919) Is Reinvesting At Lower Rates Of Return

Jan 31
Modern Healthcare Technology Holdings (HKG:919) Is Reinvesting At Lower Rates Of Return

Modern Healthcare Technology Holdings Limited's (HKG:919) Popularity With Investors Under Threat As Stock Sinks 29%

Dec 02
Modern Healthcare Technology Holdings Limited's (HKG:919) Popularity With Investors Under Threat As Stock Sinks 29%

Shareholders Will Probably Hold Off On Increasing Modern Healthcare Technology Holdings Limited's (HKG:919) CEO Compensation For The Time Being

Aug 20
Shareholders Will Probably Hold Off On Increasing Modern Healthcare Technology Holdings Limited's (HKG:919) CEO Compensation For The Time Being

Should You Be Adding Modern Healthcare Technology Holdings (HKG:919) To Your Watchlist Today?

Apr 11
Should You Be Adding Modern Healthcare Technology Holdings (HKG:919) To Your Watchlist Today?

Does Modern Healthcare Technology Holdings' (HKG:919) CEO Salary Compare Well With Industry Peers?

Feb 16
Does Modern Healthcare Technology Holdings' (HKG:919) CEO Salary Compare Well With Industry Peers?

Are Modern Healthcare Technology Holdings's (HKG:919) Statutory Earnings A Good Guide To Its Underlying Profitability?

Jan 13
Are Modern Healthcare Technology Holdings's (HKG:919) Statutory Earnings A Good Guide To Its Underlying Profitability?

We're Watching These Trends At Modern Healthcare Technology Holdings (HKG:919)

Dec 01
We're Watching These Trends At Modern Healthcare Technology Holdings (HKG:919)

이 섹션에서는 일반적으로 투자자가 회사의 수익 창출 능력을 이해하는 데 도움이 되도록 전문 애널리스트의 컨센서스 추정치를 기반으로 수익 및 수익 성장 전망치를 제시합니다. 하지만 Modern Healthcare Technology Holdings 은 충분한 과거 데이터를 제공하지 않았고 애널리스트 예측도 없기 때문에 과거 데이터를 추정하거나 애널리스트 예측을 사용하여 미래 수익을 안정적으로 계산할 수 없습니다.

SimplyWall St에서 다루는 기업의 97%가 과거 재무 데이터를 가지고 있기 때문에 이는 매우 드문 상황입니다.

수익 및 매출 성장 예측

SEHK:919 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (HKD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
3/31/2024457-106479N/A
12/31/2023426-5089101N/A
9/30/2023394-90114123N/A
6/30/2023402-55120131N/A
3/31/2023409-21126140N/A
12/31/2022394-381103N/A
9/30/2022378143766N/A
6/30/2022368-28458N/A
3/31/2022358-69-3051N/A
12/31/2021389-25575N/A
9/30/2021421183998N/A
6/30/20214277280111N/A
3/31/2021433126122124N/A
12/31/202044377104107N/A
9/30/2020452298791N/A
6/30/2020488-16577N/A
3/31/2020525-324464N/A
12/31/2019553-154772N/A
9/30/201958235080N/A
6/30/2019579-52557N/A
3/31/2019577-13134N/A
12/31/2018574-22-1414N/A
9/30/2018572-32-30-5N/A
6/30/2018585-27-39-16N/A
3/31/2018599-23-47-26N/A
12/31/2017622-3N/AN/AN/A
9/30/201764616N/A-51N/A
6/30/201767025N/A-44N/A
3/31/201769333N/A-37N/A
12/31/201671427N/AN/AN/A
9/30/201673520N/A14N/A
6/30/201675615N/A15N/A
3/31/201677710N/A15N/A
12/31/201579820N/A12N/A
9/30/201581929N/A10N/A
6/30/201584749N/A25N/A
3/31/201587469N/A40N/A
12/31/201488466N/A52N/A
9/30/201489464N/A63N/A
6/30/201488159N/A74N/A
3/31/201486955N/A84N/A
12/31/2013787-3N/A62N/A

애널리스트 미래 성장 예측

수입 대 저축률: 919 의 예상 수익 증가율이 절약률( 2.3% )보다 높은지 판단하기에는 데이터가 부족합니다.

수익 vs 시장: 919 의 수익이 Hong Kong 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: 919 의 수익이 향후 3년 동안 상당히 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

수익 대 시장: 919 의 수익이 Hong Kong 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: 919 의 수익이 연간 20% 보다 빠르게 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: 919 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.


성장 기업 발견